Eyetech Pharmaceuticals, Inc.
Records under this name other than patents Eyetech Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Eyetech Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,685,397 | Combination therapy for the treatment of ocular neovascular disorders Formerly held Lapsed on the fee record Ended Apr 1, 2022 · From the USPTO record | Lapsed on the fee record | Ended Apr 1, 2022 | From the USPTO record |
| US 8,206,707 | Combination therapy for the treatment of ocular neovascular disorders Formerly held Lapsed on the fee record Ended Jun 26, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 26, 2020 | From the USPTO record |
| US 8,187,597 | Combination therapy for the treatment of ocular neovascular disorders Formerly held Lapsed on the fee record Ended May 29, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 29, 2020 | From the USPTO record |
| US 7,759,472 | Combination therapy for the treatment of ocular neovascular disorders Formerly held Lapsed on the fee record Ended Jul 20, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jul 20, 2018 | From the USPTO record |
| US 7,785,784 | Detection of oligonucleotides by dual hybridization Formerly held Lapsed on the fee record Ended Aug 31, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 31, 2014 | From the USPTO record |